These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6302718)

  • 21. Cholecystokinin-octapeptide effects on eating elicited by "external" versus "internal" cues in rats.
    Schallert T; Pendergrass M; Farrar SB
    Appetite; 1982 Jun; 3(2):81-90. PubMed ID: 6291458
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vagotomy does not alter cholecystokinin's inhibition of sham feeding.
    Kraly FS
    Am J Physiol; 1984 May; 246(5 Pt 2):R829-31. PubMed ID: 6326619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interoceptive "satiety" signals produced by leptin and CCK.
    Kanoski SE; Walls EK; Davidson TL
    Peptides; 2007 May; 28(5):988-1002. PubMed ID: 17408804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCK-8 and CCK-58 differ in their effects on nocturnal solid meal pattern in undisturbed rats.
    Goebel-Stengel M; Stengel A; Wang L; Ohning G; Taché Y; Reeve JR
    Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(8):R850-60. PubMed ID: 22874423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-364,718, a cholecystokinin-A receptor antagonist, suppresses feeding-induced sleep in rats.
    Shemyakin A; Kapás L
    Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1420-6. PubMed ID: 11294763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin promotes sleep and reduces food intake in diabetic rats.
    Kapás L; Obál F; Farkas I; Payne LC; Sáry G; Rubicsek G; Krueger JM
    Physiol Behav; 1991 Aug; 50(2):417-20. PubMed ID: 1745688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats.
    Glatzle J; Raybould HE; Kueper MA; Reeve JR; Zittel TT
    Nutr Neurosci; 2008 Apr; 11(2):69-74. PubMed ID: 18510806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of bombesin, of a new bombesin agonist (BIM187) and a new antagonist (BIM189) on food intake in rats, in relation to cholecystokinin.
    Laferrère B; Leroy F; Bonhomme G; Le Gall A; Basdevant A; Guy-Grand B
    Eur J Pharmacol; 1992 Apr; 215(1):23-8. PubMed ID: 1516647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypnotic action of flunitrazepam is reversed by proglumide in rats.
    De Saint Hilaire-Kafi Z; Vallet PG; Gaillard JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):817-23. PubMed ID: 1763194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The feeding responses evoked by cholecystokinin are mediated by vagus and splanchnic nerves.
    Brown TA; Washington MC; Metcalf SA; Sayegh AI
    Peptides; 2011 Aug; 32(8):1581-6. PubMed ID: 21745513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of cholecystokinin-induced changes in gastric emptying and feeding in rats.
    Conover KL; Collins SM; Weingarten HP
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R21-6. PubMed ID: 3394842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholecystokinin, meal pattern, and the intermeal interval: can eating be stopped before it starts?
    Hsiao S; Wang CH; Schallert T
    Physiol Behav; 1979 Nov; 23(5):909-14. PubMed ID: 523546
    [No Abstract]   [Full Text] [Related]  

  • 35. The suppression of sucrose intake by cholecystokinin is scaled according to the magnitude of the orosensory control over feeding.
    Waldbillig RJ; Bartness TJ
    Physiol Behav; 1982 Apr; 28(4):591-5. PubMed ID: 6281827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCK-58 prolongs the intermeal interval, whereas CCK-8 reduces this interval: not all forms of cholecystokinin have equal bioactivity.
    Sayegh AI; Washington MC; Raboin SJ; Aglan AH; Reeve JR
    Peptides; 2014 May; 55():120-5. PubMed ID: 24607725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid development of tolerance to the behavioural actions of cholecystokinin.
    Crawley JN; Beinfeld MC
    Nature; 1983 Apr; 302(5910):703-6. PubMed ID: 6300693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperphagia during lactation: satiety response to CCK and growth of the pancreas.
    McLaughlin CL; Baile CA; Peikin SR
    Am J Physiol; 1983 Jan; 244(1):E61-5. PubMed ID: 6185005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholecystokinin- and secretin-induced pancreatic secretion in normal and diabetic rats.
    Sofranková A; Dockray GJ
    Am J Physiol; 1983 Apr; 244(4):G370-4. PubMed ID: 6301289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.